Strides Pharma announces completion of Bharat Dhirajlal Shah’s tenure as independent director
Shah has been associated with Strides since July 2014.
Strides announced that Bharat Dhirajlal Shah completed his second and final term as independent director of the company effective at close of business on June 14.
Shah has been associated with Strides since July 2014. The company said his rich experience in the financial services sector and expertise in the fields of banking, finance and securities market has immensely benefited the company.
[Read more: Strides Pharma receives FDA nod for generic Renvela]
The board of directors of the company stated for the record their sincere appreciation for the valuable contributions made by Shah during his association with Strides.
[Read more: Strides Pharma receives FDA nod for generic Renvela]